Osteogenesis imperfecta (OI) is a rare genetic disorder of the connective tissue. It presents with a wide spectrum of skeletal and extraskeletal features, and ranges in severity from mild to perinatal lethal. The disease is characterized by a heterogeneous genetic background, where approximately 85%-90% of cases have dominantly inherited heterozygous pathogenic variants located in the COL1A1 and COL1A2 genes. This paper presents the results of the first nationwide study, performed on a large cohort of 197 Polish OI patients. Variants were identified using a next-generation sequencing (NGS) custom gene panel and multiplex ligation probe amplification (MLPA) assay. The following OI types were observed: 1 (42%), 2 (3%), 3 (35%), and 4 (20%). Collagen type I pathogenic variants were reported in 108 families. Alterations were observed in α1 and α2 in 70% and 30% of cases, respectively. The presented paper reports 97 distinct causative variants and expands the OI database with 38 novel pathogenic changes. It also enabled the identification of the first glycine-to-tryptophan substitution in the COL1A1 gene and brought new insights into the clinical severity associated with variants localized in "lethal regions". Our results contribute to a better understanding of the clinical and genetic aspects of OI.
Keywords: COL1A1; COL1A2; collagen type I; connective tissue disorder; next-generation sequencing; osteogenesis imperfecta.
Copyright © 2023 Sałacińska, Pinkier, Rutkowska, Chlebna-Sokół, Jakubowska-Pietkiewicz, Michałus, Kępczyński, Salachna, Wieczorek-Cichecka, Piotrowicz, Chilarska, Jamsheer, Matusik, Wilk, Petriczko, Giżewska, Stecewicz, Walczak, Rybak-Krzyszkowska, Lewiński and Gach.